Atrial Fibrillation (AFib) clinical trials in Massachusetts
31 active Atrial Fibrillation (AFib) trials with a site in Massachusetts. Describe your situation to see which ones look like a fit.
- A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
- Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
- Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
- Medtronic Terminate AF Study
- Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
- The Fourth Left Atrial Appendage Occlusion Study
- A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Home Hospital for Suddenly Ill Adults
- The CONFORM Pivotal Trial
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- [64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
- Positron Emission Tomography (PET) Imaging of Thrombosis
- Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
- Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
- Quality of Life in Patients With Postoperative Atrial Fibrillation After Cardiac Surgery
- PULSED AF Post-Approval Study
- Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
- A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
- Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery
- Computerized Decision Support to Prevent Stroke in Atrial Fibrillation
- Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation
- Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF IV
- Atrial Fibrillation Risk Estimation With Single-lead Handheld Electrocardiograms
- A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF
- Warfarin Patient Self-management Implementation in the US Healthcare System
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.